Not yet recruiting
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss (SURMOUNT-4)
I8F-MC-GPHN - ClinicalTrials.gov - NCT04660643
The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue tirzepatide or switch to placebo.
How long will I be in the trial?
The study will last about 94 weeks and may include up to 25 visits.
Not yet recruiting
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss (SURMOUNT-4)
I8F-MC-GPHN - ClinicalTrials.gov - NCT04660643
The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue tirzepatide or switch to placebo.
How long will I be in the trial?
The study will last about 94 weeks and may include up to 25 visits.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have obesity or be overweight
Participants must be overweight and have high blood pressure, high cholesterol, sleep apnea or heart disease
Participants must agree to commit to and undergo study procedures as explained by clinic study staff
Participants must NOT
Participants must not have Diabetes
Participants must not have undergone weight loss surgery (e.g. stomach stapling, lap banding)
Participants must not have lost or gained weight in the last 3 months
Participants must not have chronic kidney disease
Participants must not have made prior suicide attempts
Trial Summary
Conditions the trial is for
Overweight, Very Overweight
What the trial is testing?
Tirzepatide
Could I receive a Placebo?
yes
Enrollment Goal
750
Trial Dates
April 2021 - August 2023
Trial Phase
3
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have obesity or be overweight
Participants must be overweight and have high blood pressure, high cholesterol, sleep apnea or heart disease
Participants must agree to commit to and undergo study procedures as explained by clinic study staff
Participants must NOT
Participants must not have Diabetes
Participants must not have undergone weight loss surgery (e.g. stomach stapling, lap banding)
Participants must not have lost or gained weight in the last 3 months
Participants must not have chronic kidney disease
Participants must not have made prior suicide attempts
Trial Summary
Conditions the trial is for
Overweight, Very Overweight
What the trial is testing?
Tirzepatide
Could I receive a Placebo?
yes
Enrollment Goal
750
Trial Dates
April 2021 - August 2023
Trial Phase
3
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Resources
